Takeda Pharmaceuticals is facing pending legal action in a multidistrict litigation because the company’s drug, Actos, significantly increases the risk of patients developing bladder cancer. Plaintiffs have been successful in past cases in taking legal action against the pharmaceutical company, with one jury awarding $9 million in damages. However, some…
Product Liability Lawyer Blog
Removal of Vaginal Mesh Can Have Long-Term Consequences
Vaginal mesh has been clearly demonstrated to cause serious side effects for many patients. Unfortunately, mesh products can cause significant pain, especially during intercourse. Vaginal mesh can also result in organ perforation, infection, mesh erosion and recurrent pelvic organ prolapse (POP) among the other serious symptoms and complications. At the…
Morcellator Use Can Boost Cancer Risks
Uterine fibroids are very common during a woman’s childbearing years, with as many as three out of four women developing fibroids at some point in their lives. Fibroids are often asymptomatic and are benign and almost never develop into cancer. They form from the smooth muscular tissue of the uterus,…
Boston Lipitor Attorneys Admitted to MDL
On February 18, the U.S. Judicial Panel on Multidistrict Litigation ruled that all pending federal Lipitor lawsuits should be consolidated into a multidistrict litigation. The Boston defective drug lawyers at Jeffrey Glassman Injury Lawyers LLC have filed a Lipitor case for a victim affected by this dangerous drug and our…
Older Stryker Pain Pump Lawsuit Will Not Proceed, Eighth Circuit Rules
The U.S. Court of Appeals for the Eighth Circuit has effectively dismissed plaintiff efforts to seek damages against a medical pain pump device implanted post-surgery, finding there was no way at the time of the procedure the manufacturer could have recognized the device’s potential risk. The case of Mack, et…
Teague, et al v. Johnson & Johnson, et al – TVM Defendant Motion to Transfer Mass Tort Back to Federal Court Denied
Defendants in a mass tort involving some 702 women claiming harm from transvaginal mesh medical devices were denied a request to have the case moved back to federal court, where they perceive an advantage. In theory, Boston transvaginal mesh lawyers know that both sides should be able to receive a…
Consumer Group Seeks Investigation into “Reckless” Johnson & Johnson
A nonprofit consumer advocacy group has requested that the U.S. Senate launch an investigation into Johnson & Johnson. The group alleges a pattern of “reckless” conduct. The same consumer group, the Corporate Action Network, has also urged the Department of Justice to look into whether Johnson & Johnson knowingly destroyed…
Has AMS Put Aside Enough to Resolve TVM Cases?
Bellwether cases in transvaginal mesh litigation are moving forward against American Medical Systems (AMS). A December 12, 2013 pretrial order set the first of four bellwether cases, Serrano v. AMS to start April 7, 2014. The company is currently facing as many as 16,534 lawsuits that have been consolidated into…
Covidien Vaginal Mesh Litigation
Covidien is a spinoff of Tyco Healthcare that dates back to 2007. Covidien, like many medical devices manufacturers, has produced and sold transvaginal mesh products to women as a method of treating stress urinary incontinence (SUI) and pelvic organ prolapse (POP). Covidien products including the IVS Tunneller, the Duo, Surgipro…
Stryker Prepares for Thousands of Pending Cases
Stryker has set aside $133 million in order to defend or settle cases arising from defective hip implant products. Problem products include the Stryker Rejuvenate and the Stryker ABG II. Both products contain metal components, although they are not traditional metal-on-metal hip implant systems. Unlike most hip replacement products, which…